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ABSTRACT  
Prior studies estimate that >40% of long-stay nursing home (NH) residents experience 
persistent pain, with 20% of residents in pain receiving no analgesics. Strengthened NH 
surveyor guidance and improved pain measures on the Minimum Data Set (MDS) 3.0 were 
introduced in March 2009 and October 2010, respectively. This study aimed to provide 
estimates after these important initiatives of: 1) prevalence and correlates of persistent pain; 
and 2) prevalence and correlates of untreated or undertreated persistent pain.  
We identified 1,387,405 long-stay residents in United States NHs between 2011-2012 with 2 
MDS assessments 90 days apart.  Pain was categorized as persistent (pain on both 
assessments), intermittent (pain on either assessment), or none. Pharmacologic pain 
management was classified as untreated pain (no scheduled or as needed medications 
received) or potentially undertreated (no scheduled received). Modified Poisson models 
adjusting for resident clustering within NHs provided adjusted prevalence ratios estimates (APR) 
and 95% confidence intervals (CI).  
The prevalence of persistent and intermittent pain was 19.5% and 19.2% respectively but varied 
substantially by age, gender, race/ethnicity, cognitive impairment, and cancer. Of residents in 
persistent pain, 6.4% and 32.0% were untreated or undertreated. Racial/ethnic minorities (non-
Hispanic blacks vs. whites, APR=1.19, 95% CI: 1.13–1.25) and severely cognitively impaired 
residents (severe vs. no/mild APR=1.51, 95% CI: 1.44–1.57) had an increased prevalence of 
untreated and undertreated pain. 
One in five NH residents has persistent pain. Although this estimate is greatly improved, many 
residents may be undertreated. The disturbing disparities in untreated and undertreated pain 
need to be addressed. 
Keywords: Nursing home, Epidemiology, Persistent Pain, Pharmacologic pain managementPersistent 
Pain, Pharmacologic pain management 
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INTRODUCTION 
More than 1.4 million adults in the United States (US)  live in nursing homes (<0.001% of 
the US population <65 years old; 2.8% of the US population >65 years old; and 10.4% of the US 
population >85 years old).[3] This care setting is particularly important to the most vulnerable 
among us including the oldest old (≥85 years), those with moderate to severe cognitive and/or 
functional impairment, and the dying.[5,44] As the population continues to age, this setting will 
become increasingly important for the care of these vulnerable populations.  
Essential to residents’ quality of life is the appropriate management of pain, which 
affects 35% of all nursing home residents.[3] Historically, pain has been untreated or 
undertreated in US nursing homes, with approximately 20% of all residents experiencing 
malignant or nonmalignant pain receiving no pharmacologic pain management.[2,51,52] 
However, previous studies of pain and pain management may not be applicable to current 
practice in US nursing homes because they preceded Centers for Medicare and Medicaid 
Services (CMS) policy changes including strengthened nursing home surveyor guidance in 
2009 (F-tag 309), and preceded the 2010 introduction of Minimum Data Set (MDS) 3.0 with 
enhanced pain measures. [2,8,18,20,23,31,36,38,40,43,45,51–53] Declining trends in the 
prevalence of moderate to severe pain between 2006 and 2009 are encouraging.[8,40]  Yet, 
questions remain on the overall burden of pain and the degree to which it may be currently 
untreated or potentially undertreated in US nursing homes.[40]  
The Institute of Medicine called for “better data” to enhance the understanding of pain 
and pain management strategies in vulnerable populations, such as nursing home residents.[16] 
Therefore, using comprehensive, national data from 2011-2012 of all long-stay US nursing 
home residents, we conducted this study to estimate: 1) the prevalence and correlates of 
intermittent and persistent pain; and 2) the prevalence and correlates of untreated or potentially 
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undertreated persistent pain in US nursing home residents. Although we had no prior 
hypotheses on the overall burden of pain, we did hypothesize that older residents, men, 
racial/ethnic minorities, and cognitively impaired residents would have a higher prevalence of 
untreated and potentially undertreated pain.  
METHODS  
Study Design and Data Source 
 We used routinely-collected administrative data from 2011-2012 to conduct a cross-
sectional study. We created our cohort using the Minimum Data Set 3.0, a federally required, 
standardized assessment of all nursing home residents living in Medicare- or Medicaid-certified 
homes (approximately 96% of all nursing homes). The MDS 3.0 includes more than 450 items 
to assess residents’ overall health including pain, cognition, mood, functional status, medical 
conditions, and other measures.[35,36,38] Comprehensive MDS 3.0 assessments are 
completed by registered nurses at admission, annually, and whenever there is a significant 
change in status. Condensed quarterly assessments are conducted at 90 day intervals between 
comprehensive assessments.  
The University of Massachusetts Medical School Institutional Review Board approved 
this study. 
Study Sample 
We identified a sample of long-stay nursing home residents during 2011-2012, defined 
as residents with: 1) >100 cumulative days in the same nursing home with no gaps in residency 
>30 days; and 2) a comprehensive or quarterly MDS assessment in the study period 
(n=1,697,384). We focused on long-stay residents because they require long-term assistance to 
manage their chronic disabilities (average length of stay of ~2 years). [49] In contrast, short-stay 
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residents or those receiving skilled nursing facility (SNF) care are predominately recovering 
from acute illnesses and are normally in the nursing home for a limited period of time before 
being discharged to the community (average length of stay of ~40 days). [49] 
Eligible long-stay residents had to have a comprehensive or quarterly MDS assessment 
(the index assessment) that was: 1) preceded by a prior (comprehensive or quarterly) MDS 
assessment 90 +/- 20 days before the index assessment; and 2) had a comprehensive 
assessment within 180 days of the index assessment (98,311 with no prior assessment, 85,336 
with no comprehensive MDS assessment). These study design criteria were necessary because 
residents without a comprehensive or quarterly assessment had limited information on pain and 
other important study variables, residents with no prior MDS assessment 90 +/- 20 days before 
the index assessment could not be assessed for persistent pain (pain present on two MDS 
assessments approximately three months apart, described in detail below), and residents 
without a comprehensive assessment were missing  data on important potential causes of pain 
(e.g., cancer, arthritis, and osteoporosis) that were not available on the condensed, quarterly 
MDS assessments.  We additionally excluded long-stay residents who received SNF care at or 
within 30 days of the index date because of differences between those needing SNF care and 
other long-stay residents highlighted above (n=24,947).[49] For the remaining eligible residents, 
we randomly chose an index assessment for those with multiple eligible assessments 
(1,488,790 unique residents). Of these residents, we further excluded those who were 
comatose (n=5,194), <18 years old (n=1,436), or missing data on important covariates 
(n=94,755). The final analytic sample included 1,387,405 residents. See eFigure 1 in 
supplemental appendix for more detail. 
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Pain and Pain Management 
 On the MDS 3.0, all measures of pain are included on quarterly or comprehensive 
assessments. Prior studies that compared the inter-rater agreement between facility nurses and 
gold-standard research nurses found that these items have excellent reliability. (κ > 0.96).[35] 
We first categorized the presence of pain at the index and preceding MDS assessment. For 
each assessment, the registered nurse administering the MDS asked residents who were 
cognitively and physically able to self-report (≥90% of all long-stay residents)[46] on the 
presence of pain in the 5 days before each assessment. For residents who self-reported pain, 
information on frequency (rarely, occasionally, frequently, or constantly) and severity of the 
worst pain in the lookback period was collected.   Residents rated pain severity using either the 
Verbal Descriptor Scale (categorizing pain as mild, moderate, severe, or very severe/horrible) or 
the Numeric Pain Scale (categorizing pain from 0 [no pain] to 10 [very/severe horrible pain]). A 
validated crosswalk was used to compare the two scales.[7] We used the Centers for Medicare 
and Medicaid Services (CMS) quality indicator definition of pain to categorize self-reporting 
residents as having no pain, mild/infrequent pain (mild to severe pain occurring rarely or 
occasionally), or moderate/severe pain (moderate/severe pain occurring frequently or almost 
constantly or very severe/horrible occurring at any frequency).[3] For residents who could not 
self-report their pain, staff review the medical record, consult other staff, and directly observe 
the resident to ascertain indicators of pain (e.g., crying, moaning, grimacing) and frequency of 
pain in the previous five days. We categorized staff-assessed pain as no pain, infrequent pain 
(1-2 days), or frequent pain occurring ≥ 3 days.[15] For our analyses, we combined self-reported 
moderate/severe pain and staff-assessed frequent pain, self-reported mild/infrequent pain and 
staff-assessed infrequent pain, and no self-reported pain and no staff-assessed pain.  
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We were conceptually interested in the prevalence of persistent pain, defined according 
to prior guidelines as pain with a duration ≥3 months.[1] To operationally define persistent pain, 
we evaluated the index and preceding assessments. Residents were considered to have 
persistent pain if pain was documented at both assessments. We categorized residents as 
having intermittent pain if they had pain at either (but not both) assessments. Residents with no 
pain documented on both assessments were categorized as having no pain.  
We assessed whether residents received pharmacologic pain management at the index 
assessment using MDS 3.0 J0100. These items have excellent reliability in a study of inter-rater 
agreement between gold-standard research nurses and facility nurses (κ > 0.92).[35] Nurses 
record whether the resident received a scheduled pain regimen or as needed (pro re nata, PRN) 
pain medication in the five days prior to the assessment based on medical record review. We 
defined residents as having untreated pain if they experienced any pain at the index 
assessment or had persistent pain and received no pharmacologic pain management. For those 
in persistent pain, we considered residents as having potentially undertreated pain if they did 
not receive scheduled analgesics or PRN medications as recommended by treatment guidelines 
for malignant and nonmalignant pain.[1,11]  
Resident Characteristics 
We evaluated resident characteristics that may influence pain ascertainment or receipt 
of analgesics based on prior literature.[2,8,23,31,51] This included age (<65 years, 65-74 years, 
75-84 years, >85 years), gender, race/ethnicity (non-Hispanic White, non-Hispanic Black, 
Hispanic, other), physical functioning, cognitive functioning, whether the resident rejected care 
in the previous 7 days (e.g., taking medications, activities of daily living [ADL] assistance), 
hospice use in the previous 14 days, and active comorbidities associated with pain (e.g., 
fractures, arthritis, osteoporosis). We categorized residents’ cognitive impairment using CMS 
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definitions based on either the Brief Interview of Mental Status (BIMS; range 0-15) for residents 
who could self-report or the Cognitive Performance Scale (CPS; range 0-6) for those unable to 
self-report.[3,25,37] Residents were categorized as having no or mild impairment (BIMS 13-15 
or CPS 0-2), moderate impairment (BIMS 8-12 or CPS 3-4), or severe impairment (BIMS 0-7 or 
CPS 5-6). We categorized physical functioning using the MDS-ADL Self-Performance Hierarchy 
(range 0-7) to categorize residents as totally dependent (5-6), extensively dependent (3-4) or no 
to limited impairment (0-2).[26]  
Analysis 
We conducted descriptive analyses to describe the overall prevalence of persistent and 
intermittent pain by severity/frequency of pain reported at both the preceding and index MDS 
assessments. We conducted stratified analyses to examine variation in persistent and 
intermittent pain by demographics, cognitive impairment, and cancer. We  evaluated correlates 
of intermittent and persistent pain (while adjusting for potential confounders) using multinomial 
logistic models with robust variance estimation to calculate adjusted odds ratios (AOR) and 95% 
confidence intervals (CI) that accounted for the clustering of NH residents within facilities.[50]  
We described pharmacologic pain management strategies by the level of pain reported 
on the index assessment and persistent pain to quantify the prevalence of untreated pain. For 
the subset of residents in persistent pain, we estimated the association between resident 
characteristics and being pharmacologically untreated or potentially undertreated using modified 
Poisson models with robust variance estimation to calculate adjusted prevalence ratios (APR) 
with 95% CI while accounting for the clustering of NH residents within facilities.[55,56] 
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Because of our large sample size, we did not use statistical significance as a threshold 
to evaluate whether our results were clinically significant.[13] Rather, we considered effect 
estimates ≥10% (AORs or APRs ≥1.10 or ≤0.90) as being potentially relevant to clinicians and 
policymakers.[43]  
We conducted several additional analyses to examine potentially meaningful differences 
in pain reporting and pharmacologic pain management in our study population. First, we 
stratified by cancer status to investigate whether there were differences in pain prevalence, 
general pharmacologic management, and correlates of untreated or undertreated pain due to 
cancer status and source of pain. Although general pain management strategies should not 
differ by cancer status (e.g., residents should receive medication – with preference for 
scheduled analgesics – to manage persistent pain regardless of whether pain is due to cancer 
or not), we conducted these analyses to compare our results to prior studies that restricted 
sample to residents with malignant or nonmalignant pain.[2,8,31,51,52] Second, we conducted 
sensitivity analyses examining whether correlates of untreated and potentially undertreated pain 
remained after restricting our sample to those reporting moderate-to-severe/frequent pain only. 
We wanted to know if the potential burden of untreated and undertreated pain would be the 
same in this restricted population in the most pain and compare these results to a prior study 
that used a similar operational definition.[8] Finally, we conducted sensitivity analyses to 
examine pain prevalence, pharmacologic management, and correlates of untreated or 
potentially undertreated pain after restricting our sample to those who were able to self-report 
their own pain and were not severely cognitively impaired. These analyses address concerns of 
potential differences in pain ascertainment by cognitive status and aid in comparing our results 
to previous studies that used similar restrictions.[8,51,52] 
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RESULTS 
  More than one-third of long-stay nursing home residents experienced intermittent 
(19.1%) or persistent pain (19.5%) over the 3-month study period. A small proportion of 
residents (4.2%) had documented moderate-to-severe/frequent pain at both assessments. Of 
those with initial reports of moderate-to-severe/frequent pain (n=155,174), 27.4% had mild and 
35.1% had no pain documented at the next assessment. Conversely, 5.1% and 16.7% of those 
experiencing no or mild/infrequent pain at their first assessment reported moderate/severe pain 
at the second assessment, respectively. 
 Figure 1 shows there were differences in the unadjusted prevalence of overall pain and 
persistent pain by resident age, gender, race/ethnicity, cognitive impairment, and cancer status. 
Older residents had less documented pain than younger residents, with the oldest old reporting 
substantially less overall (35.5% vs. 44.3%) and persistent pain (15.9% vs. 27.1%) than 
residents 18-64 years old. Men reported less overall pain than women (35.3% vs. 40.2%). 
Racial/ethnic minorities reported less overall (31.3% vs. 40.6%) and persistent pain (14.9% vs. 
20.7%) in comparison to non-Hispanic white residents. Moderately and severely cognitively 
impaired residents reporting lower levels of overall pain (moderate: 38.2%; severe: 27.4%) and 
persistent pain (moderate: 18.4%; severe: 10.5%) than residents with no/mild cognitive 
impairment (overall pain: 56.1%; persistent pain: 34.1%). Residents with cancer reported more 
overall pain than residents without cancer (44.5% vs 38.2%), though differences in persistent 
pain (22.9% vs. 19.2%) were less pronounced. 
 Table 1 shows that the differences noted in Figure 1 continued to be largely associated 
with documented persistent and intermittent pain after adjusting for other resident 
characteristics. In particular, racial/ethnic minorities reported less persistent and intermittent 
pain (relative to no pain), with non-Hispanic blacks reporting less persistent (AOR=0.66, 95% 
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CI: 0.63–0.69) and intermittent pain (AOR=0.75, 95% CI: 0.73–0.76) than non-Hispanic whites. 
Additionally, cognitive impairment was strongly inversely associated with persistent (severely 
impaired vs. no impairment: AOR=0.26, 95% CI: 0.25–0.26) and intermittent pain (severely 
impaired vs. no impairment: AOR=0.48, 95% CI: 0.47 – 0.49). Additional factors that increased 
the odds of being in intermittent or persistent pain included rejecting care (persistent pain only), 
hospice use, arthritis, fractures, pressure ulcers, and surgical wounds. Other markers of 
cognitive impairment including dementia and staff-assessed pain (persistent pain only) were 
inversely associated with documented pain. 
 Figure 2 shows that untreated pain was uncommon with 8.9% and 6.6% of residents in 
any pain at the index assessment and persistent pain receiving no pharmacologic pain 
management, respectively. Nearly one-third of those in persistent pain (32.0%) received no 
scheduled analgesics. Scheduled analgesics were used by 34.4% of residents reporting no pain 
at index, 63.2% of those reporting any pain (mild/infrequent pain: 63.8%; moderate-to-
severe/frequent pain: 62.1%) at index, and in 68.0% of those in persistent pain.  
 Table 2 shows the correlates of untreated and potentially undertreated persistent pain in 
our adjusted statistical models. Being older (e.g., ≥85 years vs 65-74 years: APR=1.42, 95% CI: 
1.35–1.49), non-Hispanic black or other race/ethnicity vs. non-Hispanic white (non-Hispanic 
black: APR=1.19, 95% CI: 1.13–1.25; other: APR=1.15, 95% CI: 1.03–1.29), and cognitively 
impaired vs. no/mild impairment (moderate impairment: APR=1.24, 95% CI: 1.19–1.29; severe 
impairment: APR=1.51, 95% CI: 1.44–1.57) were strongly associated with untreated pain. 
Alternatively, women were less likely than men to receive no pharmacologic pain management 
(APR=0.76, 95% CI: 0.74–0.79). Other factors associated with a reduced prevalence of 
untreated pain included receipt of hospice care, having cancer, arthritis, fractures, pressure 
ulcers, or surgical wounds. Other markers of cognitive impairment such as dementia were also 
associated with a higher prevalence of untreated pain. When examining correlates of potentially 
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undertreated pain (not receiving scheduled analgesics), residents who were a racial/ethnic 
minority vs. non-Hispanic white (non-Hispanic black: APR=1.23, 95% CI: 1.20–1.25; Hispanic: 
APR=1.18, 95% CI=1.14 –1.22; other: APR=1.11, 95% CI: 1.05–1.17), those with moderate to 
severe cognitive impairment vs. those with no/mild cognitive impairment (moderate: APR=1.11, 
95% CI: 1.09–1.12; severe: APR=1.14, 95% CI: 1.11–1.16), and those with fractures (vs. no 
fractures) or surgical wounds (vs. no surgical wounds) had a higher prevalence of potentially 
undertreated pain. Alternatively, residents receiving hospice care (vs. no hospice care), and 
those with arthritis (vs. no arthritis), osteoporosis (vs. no osteoporosis), or pressure ulcers (vs. 
no pressure ulcers) had a lower prevalence of potentially undertreated persistent pain. 
 In analyses stratified by cancer status and demographics/cognitive impairment, residents 
with cancer had more overall persistent (+3.7% on average) and intermittent (+2.6% on 
average) pain than residents with nonmalignant pain (eTable 1 in Supplementary Appendix). 
Younger persons with cancer reported far greater levels of persistent pain than those with 
nonmalignant pain (e.g., residents with cancer, 18-64 years old: 35.4%; residents with 
nonmalignant pain, 18-64 years old: 25.8%). Those with cancer were less likely to have 
untreated or potentially undertreated pain at the index assessment in comparison to those with 
nonmalignant pain (eTable 2-3). Risk factors for untreated and potentially undertreated pain 
were similar regardless of whether the resident experienced malignant or nonmalignant pain 
(eTable 4-5). Analyses restricted to those in the most severe pain did not substantially alter our 
finding on the prevalence and correlates of untreated/undertreated pain (eTable 6-7). When we 
restricted our sample to those who were able to self-report pain and were not severely 
cognitively impaired, the prevalence of persistent pain and intermittent pain increased to 28.1% 
and 20.5%, respectively (eTable 8). However, the prevalence and correlates of untreated or 
potentially undertreated persistent pain did not substantially change (eTable 9-11). 
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DISCUSSION 
 In 2011-2012, 38.6% of long-stay NH residents experienced any pain, with nearly one in 
five residents having persistent pain. Among those in persistent pain, 6.4% received no 
pharmacologic pain management and over 30% received no scheduled analgesics.  Our 
estimates of persistent pain prevalence in long-stay nursing home residents are substantially 
lower than historical estimates that range from to 41-49%.[45,52,53] Given that many of the 
older studies use data >15 years old,[45,52,53] possible explanations for the lower pain 
prevalence in our study may include: 1) heightened attention to pain treatment through 
introduction of pain quality indicators (2002);2)strengthened surveyor guidance that holds 
nursing homes accountable for assessing and treating pain  (F309; 2009) [18]; 3) improved 
measures in MDS 3.0 that emphasize “the resident voice” and highlight previously unmet needs 
in pain management  (2010)[36,46]; 4) change in payment for analgesics with the introduction of 
Medicare Part D implementation that made medications more affordable for Medicare 
beneficiaries (2006); and 3) the growth of hospice and palliative careduring the last 15 years in 
this care setting.[24] It is unclear to what extent individual policy and culture changes may have 
potentially lowered pain prevalence, though studies and CMS reports have documented 
declines in reported pain between 2006 and 2013.[3,4,40] We believe that study design issues 
only partially explain differences in our estimate of persistent pain in comparison to prior 
national studies. Such differences include differing operational definitions of persistent pain, our 
inclusion of residents with severe cognitive impairment or those unable to self-report, and 
changes in pain ascertainment between MDS 2.0 and 3.0.[8,40,45,52,53] Sensitivity analyses 
intended to mimic restrictions used in prior research demonstrated that the substantial 
reductions in overall persistent pain were not due to our study design decision-making. 
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 Despite large reductions in the absolute prevalence of persistent pain, we found 
demographic and clinical trends in the prevalence of pain that are consistent with prior US 
research.[2,8,19,31,40,43,51,52]. In particular, younger residents, women, non-Hispanic whites, 
those with cancer, and those with no or mild cognitive impairment reporting higher levels of 
pain. Older adults, racial and ethnic minorities, and men may systematically underreport their 
pain, potentially due to cultural pressure to be stoic and intimidation to report their pain to health 
professionals.[12,14,17,27,28,39,54] Our estimates of pain may be conservative in these 
subgroups. Among residents with moderate or severe cognitive impairment, reports of pain 
were much lower than in those with no or mild impairment. It is unclear if pain was appropriately 
assessed in this group. Prior studies indicate that pain can be appropriately assessed in many 
residents with moderate to severe impairment,[10,21,29,30] and the majority of long-stay 
residents do self-report.[46] However, excluding residents with severe cognitive impairment or 
those who were unable to self-report dramatically increased our estimates of persistent pain 
prevalence from 19.5% to 28.1%. Continued efforts to improve pain ascertainment in such 
vulnerable NH residents is appropriate. 
 We found that 6.4% of long-stay nursing home residents in persistent pain received no 
pharmacologic pain management. This estimate is significantly lower than the 24.5% reported 
by Won et al., 2004 using data from 1998-2000 and 16.7% reported by Fain et al., 2016 using 
2008 data.[8,52] Potential decreases in untreated pain prevalence could be due to the policy 
changes highlighted above, though the relative influence of each policy change is unknown. 
Alternatively, prior studies using MDS 2.0 either measured analgesic use based on nursing staff 
reporting or Part D claims, which may results in some misclassification of pain medication use, 
especially  for commonly prescribed over-the-counter medications (e.g., acetaminophen) not 
covered by Part D.[41] Although reductions in untreated pain appear to have occurred, current 
pain management practices may still be suboptimal. More than one-third of long-stay residents 
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in persistent pain received no scheduled analgesics despite their recommended use in pain 
management guidelines.[1]  It is unclear from our data what specific medications are being used 
to manage pain in long-stay residents.  
 Disparities in pharmacological management of persistent pain continue in the US. Older 
nursing home residents, non-Hispanic blacks, and those with cognitive impairment and/or 
dementia diagnosis had a higher prevalence of untreated pain. Prior studies conducted over the 
past 18 years have also documented these gaps in untreated pain prevalence. 
[2,8,20,23,31,51,52]  When examining potentially undertreated pain, racial/ethnic disparities 
increased with non-white residents in persistent pain receiving less scheduled analgesics than 
non-Hispanic white residents. It is unclear why these disparities continue, though others have 
suggested that they may be due to potential implicit bias in healthcare providers.[8,34] The time 
has come to conduct research on how best to promote equity in pain management in this 
vulnerable population.  Some clinical characteristics were associated with a decreased 
prevalence of untreated or potentially undertreated pain. In general, residents in persistent pain 
with comorbidities known to cause pain (e.g., arthritis, fractures) had a lower prevalence of 
untreated or undertreated pain, though residents with fractures or surgical wounds were less 
likely to receive scheduled analgesics than other residents. This discrepancy may be due to the 
acuteness of these injuries. However, given concern that acute pain may be a significant cause 
of persistent pain if not properly treated,[1] further research is needed to understand how these 
types of injuries are treated over time in long-stay residents. In addition to painful comorbidities, 
receipt of hospice care was associated with a lower prevalence of untreated and potentially 
undertreated persistent pain. Hospice may give residents access to superior palliative care in 
comparison to traditional nursing home care, and prior studies document a strong association 
between hospice care and receipt of pharmacologic pain management.[15,23] Yet, these 
services are only available to residents with terminal diagnoses who elect hospice. Further 
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interventions and policies may be needed to disseminate palliative care practices into a care 
setting that has traditionally prioritized improving and maintaining resident function over holistic 
resident-centered care. 
 Although our discussion has focused on the US context, pain and pain management in 
nursing home is an international issue.[47] A systematic review identifying studies from 
Australia, Canada, China, Taiwan, Singapore, Iran, Norway, the Netherlands, and the United 
Kingdom found pain prevalence to be highly prevalent, ranging from  27.8-79.5%.[42] Further, in 
many cases pain management was not provided or inadequate, particularly for those with 
cognitive impairment. Similar trends in international pain prevalence and untreated/undertreated 
pain have also been reported.[22]  This study has several strengths. First, we used 
comprehensive, national data from 2011-2012 that included more than 1.3 million long-stay 
nursing home residents. Our results are generalizable to nursing home residents in Medicare- or 
Medicaid certified homes. Second, through the MDS 3.0 we had access to enhanced pain 
assessments not available in previous national samples examining pain management. Third, we 
were able to measure analgesic use using the MDS 3.0. Because this is based on medical 
record review, it may more accurately capture medication use that may not be included in 
pharmaceutical claims such as over-the-counter medication.[41] However, this study also had 
limitations. We could only assess pain when the resident had an MDS assessment (required 
every 90 days). We lacked information on pain between assessments.  Additionally, our study 
design excluded long-stay residents without prior assessments or comprehensive assessments 
within 180 days of the index assessment and those with missing data. Although our results may 
not be generalizable to these residents, further examination of their reported pain suggests that 
their exclusion did not substantially alter study findings. We also note large differences in pain 
reporting between those with no/mild impairment and more severe cognitive impairment, we 
were concerned that there may be under-ascertainment of pain. However, prior studies 
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emphasize that even those with severe cognitive impairment can still accurately self-report 
pain.[10,21,29,30]  We conducted sensitivity analyses restricting our sample to those without 
severe cognitive impairment or unable to self-report – overall prevalence of pain was affected 
but correlates of untreated and potentially undertreated pain were similar to primary analyses. 
We also lacked detailed information on specific medications used, so we could only comment 
on general pain management strategies recorded on the MDS. Finally, we specifically focused 
on pharmacologic interventions, but non-pharmacologic interventions (e.g., physical therapy, 
nerve blocks, electrical stimulation) are also important in the management of pain.[33,48] 
In conclusion, we found that the prevalence of persistent pain and untreated persistent 
pain were dramatically lower than previously reported estimates from data sources predating 
major national initiatives that could potentially influence the ascertainment and treatment of 
pain. However, many residents in persistent pain may still be undertreated, as the use of 
scheduled analgesics was low despite guideline recommendations for their use. Previously 
documented disparities in treatment are still present and require attention to improve the quality 
of nursing home care for all residents. Further work is needed to characterize the 
appropriateness of current pain management practices, as nursing homes have a documented 
history of poor pain management practices beyond underuse,[6,9,32] and the overall prevalence 
of pain is still high despite improvements.  
ACKNOWLEDGMENTS 
Conflicts of Interest: JT is consultant with CVS Caremark for the National Pharmacy and 
Therapeutics Committee. All other authors: None. 
JNH was supported by NIH grant 1TL1TR001454. 
CMU was supported by NIH grants 1R56NR015498-01, and R21CA198172-02. 
JT was supported by NIH grant R56NR015498-01, R21CA198172-02, and a  
AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
17 
 
Sojourns Scholar Leadership Award from the Cambia Health Foundation.   
KLL was supported by NIH grants 1TL1TR001454, 1R56NR015498-01, and R21CA198172-02. 
REFERENCES 
[1] American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in 
Older Persons. Pharmacological management of persistent pain in older persons. J Am 
Geriatr Soc 2009;57:1331-46. 
[2] Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis, C, Dunlop R, Lipsitz L, Steel K, 
Mor V. Management of pain in elderly patients with cancer. SAGE Study Group. 
Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998;279:1877-
82. 
[3] Centers for Medicare and Medicaid Services. Nursing Home Data Compendium, 2015 
Ed. [on-line]. Available at https://www.cms.gov/Medicare/Provider-Enrollment-and-
Certification/CertificationandComplianc/Downloads/nursinghomedatacompendium_508-
2015.pdf. Accessed December 5, 2016.  
[4] Centers for Medicare and Medicaid Services. Nursing Home Data Compendium, 2013 
Ed. [on-line]. Available at https://www.cms.gov/Medicare/Provider-Enrollment-and-
Certification/CertificationandComplianc/downloads/nursinghomedatacompendium_508.pd
f. Accessed December 5, 2016.  
[5] David S, Sheikh F, Mahajan D, Greenough W, Bellatoni M. Whom do we serve? 
Describing the target population for post-acute and long-term care, focusing on nursing 
facility settings, in the era of population health. J Am Med Dir Assoc 2016;17:574-80.  
[6] Dosa DM, Dore DD, Mor V, Teno JM. Frequency of long-acting opioid analgesic initiation 
in opioid-naïve nursing home residents. J Pain Symptom Manage. 2009;38:515-21.  
AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
18 
 
[7] Edelen MO, Saliba D. Correspondence of verbal descriptor and numeric rating scales for 
pain intensity: an item response theory calibration. J Gerontol A Biol Sci Med Sci 
2010;65:778–85. 
 [8] Fain KM, Alexander GC, Dore DD, Segal JB, Zullo AR, Castillo-Salgado C. Frequency 
and predictors of analgesic prescribing in US nursing home residents with persistent pain. 
J Am Geriatr Soc 2016. Published  online ahead of print.  
 [9] Fain KM, Castillo-Salgado C, Dore DD, Segal JB, Zullo AR, Alexander GC. Inappropriate 
Fentanyl Prescribing Among Nursing Home Residents in the United States. J Am Med Dir 
Assoc 2016. Published online ahead of print. 
[10] Fisher SE, Burgio LD, Thorn BE, Hardin JM. Obtaining self-report data from cognitively 
impaired elders: methodological issues and clinical implications for nursing home pain 
assessment. Gerontologist 2006;46:81-8.  
[11] Gordon DB, Dahl JL, Miaskowski C McCarberg B, Todd KH, Paice JA, Lipman AG, 
Bookbinder M, Sanders SH Turk DC, Carr DB. American pain society recommendations 
for improving the quality of acute and cancer pain management: American Pain Society 
Quality of Care Task Force. Arch Intern Med 2005;165:1574-80. 
[12] Green CR, Anderson KO, Baker TA, Campbell LC, Decker S, Fillingim RB, Kalauokalani 
DA, Lasch KE, Myers C, Tait RC, Todd KH, Vallerand AH. The unequal burden of pain: 
confronting racial and ethnic disparities in pain. Pain Med 2003;4:277-94. 
[13] Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. 
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. 
Eur J Epidemiol 2016;31:337-50. 
[14] Hadjistavropoulos T, Herr K, Turk DC, Fine PG, Dworkin RH, Helme R, Jackson K, 
AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
19 
 
Parmelee PA, Rudy TE, Lynn Beattie B, Chibnall JT, Craig KD, Ferrell B, Ferrell B, 
Fillingim RB, Gagliese L, Gallagher R, Gibson SJ, Harrison EL, Katz B, Keefe FJ, Lieber 
SJ, Lussier D, Schmader KE, Tait RC, Weiner DK, Williams J.  An interdisciplinary expert 
consensus statement on assessment of pain in older persons. Clin J Pain 2007;23:S1-43.  
[15] Hunnicutt JN, Tjia J, Lapane KL. Hospice use and pain management in elderly nursing 
home residents with cancer. J Pain Symptom Manage 2016. Published online ahead of 
print. 
[16] IOM, Relieving  pain in America: a blueprint for transforming prevention, care, education, 
and research. The National Academies Press; 2011. 
[17] Kaye AD, Baluch A, Scott JT. Pain management in the elderly population: a review. 
Ochsner J 2010;10:179-87.  
[18] Lapane KL, Quilliam BJ, Chow W, Kim MS. Impact of revisions to the F-Tag 309 
surveyors’ interpretive guidelines on pain management among nursing home residents. 
Drugs Aging 2012;385-93. 
[19] Lapane KL, Quilliam BJ, Chow W, Kim MS.  The association between pain and measures 
of well-being among nursing home residents. J Am Med Dir Assoc 2012;13:344-9. 
[20] Lapane KL, Quillaim BJ, Chow W, Kim MS. Pharmacologic management of non-cancer 
pain among nursing home residents. J Pain Symptom Manage 2013;45:33-42. 
[21] Lin WC, Lum TY, Mehr DR, Kane RL. Measuring pain presence and intensity in nursing 
home residents. J Am Med Dir Assoc 2006;7:147-53. 
[22] Lukas A Mayer B, Fialova D, Topinkova E, Gindin J, Onder G, Bernabei R, Nikolaus T, 
Denkinger MD. Pain Characteristics and Pain Control in European Nursing Homes: 
AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
20 
 
Cross-sectional and Longitudinal Results From the Services and Health for Elderly in 
Long TERm care (SHELTER) Study. J Am Med Dir  Assoc 2013;14:421–8. 
[23] Miller SC, Mor V, Wu N, Gozalo P, Lapane K. Does receipt of hospice care in nursing 
homes improve the management of pain at the end of life? J Am Geriatr Soc 
2002;50:507-15. 
[24] Miller SC, Lima J, Gozalo PL, Mor V. The growth of hospice care in U.S. nursing homes. 
J Am Geriatr Soc 2010;58:1481-8. 
[25] Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, Lipsitz LA. MDS cognitive 
performance scale. J Gerontol 1994;49:M174-82. 
[26] Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS.  J Gerontol A Biol Sci Med 
Sci 1999;54:M546-53. 
[27] Mossey JM. Defining racial and ethnic disparities in pain management. Clin Orthop Relat 
Res 2011;469:1859-70. 
[28] Myers CD, Rileey JL, Robinson ME. Psychosocial contributions to sex-correlated 
differences in pain. Clin J Pain 2003;19:225-32. 
[29] Pautex S, Herrmann F, Le Lous P, Fabjan M, Michel JP, Golg G. Feasibility and reliability 
of four pain self-assessment scales and correlation with an observational rating scale in 
hospitalized elderly demented patients. J Gerontol A Biol Sci Med Sci 2005;60:524-9. 
[30] Pautex S, Michon A, Guedira M, Emond H, Le Lous P, Samaras D, Michel JP, Hermann 
F, Giannakopoulos P, Gold G. Pain in severe dementia: self-assessment or observational 
scales? J Am Geriatr Soc 2006;54:1040-5. 
 
AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
21 
 
[31] Pimentel CB, Briesacher BA, Gurwitz JH, Rosen AB, Pimentel MT, Lapane KL. Pain 
management in nursing home residents with cancer. J Am Geriatr Soc 2015;63:633–641. 
[32] Pimentel CB, Gurwitz JH, Tjia J, Hume AL, Lapane KL. New initiation of long-acting 
opioids in long-stay nursing home residents. J Am Geriatr Soc 2016;64:1772-8. 
[33] Portenoy RK. Treatment of cancer pain. Lancet 2011;377:2236–47. 
[34] J.A. Sabin, A.G. Greenwald, The influence of implicit bias on treatment recommendations 
for 4 common pediatric conditions: pain, urinary tract infection, attention deficit 
hyperactivity disorder, and asthma., Am. J. Public Health. 102 (2012) 988–95. 
[35] Saliba D, Buchanan J. Development and validation of a revised nursing home 
assessment tool: MDS 3.0. Rand Corp. Santa Monica, 2008. 
[36] Saliba D, Buchanan J. Making the investment count: revision of the Minimum Data Set for 
nursing homes, MDS 3.0. J Am Med Dir Assoc 2012;13:602–610. 
[37] Saliba D, Buchanan J, Edelen MO, Streim J, Ouslander J, Berlowitz D, Chodosh J. MDS 
3.0: brief interview for mental status. J Am Med Dir Assoc 2012;13:611-7.  
[38] Saliba D, Jones M, Streim J, Ouslander J, Berlowitz D, Buchanan J. Overview of 
significant changes in the Minimum Data Set for nursing homes version 3.0. J Am Med 
Dir Assoc 2012;13:595–601. 
[39] Shavers VL, Bakos A, Sheppard VB. Race, ethnicity, and pain among the US adult 
population. J Health Care Poor Underserved 2010;21:177-220.  
[40] Shen X, Zucerkman IH, Palmer JB, Stuart B. Trends in prevalence for moderate-to-
severe pain and persistent pain among medicare beneficiaries in nursing homes, 2006–
2009. J Gerontol A Biol Sci Med Sci 2015;70:598-603. 
AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
22 
 
[41] Simoni-Wastila L, Stuart BC, Shaffer T. Over-the-counter drug use by Medicare 
beneficiaries in nursing homes: implications for practice and policy. J Am Geriatr Soc 
2006;54:1543-9. 
[42] Takai Y, Yamamoto-Mitani N, Okamoto Y, Koyama K, Honda A. Literature review of pain 
prevalence among older residents of nursing homes. Pain Manag Nurs 2010;11:209–23. 
[43] Teno JM, Kabumoto G, Wetle T, Roy J, Mor V. Daily pain that was excruciating at some 
time in the previous week: prevalence, characteristics, and outcomes in nursing home 
residents. J Am Geriatr Soc 2004;52:762-7. 
[44] Teno JM, Gozalo PL, Bynum JP, Leland NE, Miller SC, Morden NE, Scupp T, Goodman 
DC, Mor V. Change in end-of-life care for Medicare beneficiaries: site of death, place of 
care, and health care transitions in 2000, 2005, and 2009. JAMA 2013;309:470-7. 
[45] Teno JM, Weitzen S, Wetle T, Mor V. Persistent pain in nursing home residents. JAMA 
2001; 285: 2081. 
[46] Thomas KS, Wysocki A, Intrator O, Mor V. Finding Gertrude: the resident’s voice in 
Minimum Data Set 3.0. J Am Med Dir Assoc 2014;15:802-6. 
[47] Tolson D, Rolland Y, Andriu S, Aquino JP, Beard J, Benetos A, Berrut G, Coll-Planas L, 
Dong B, Forette F, Franco A, Franzoni S, Salva A, Swagerty D, Trabucci M, Vellas B, 
Volicer L, Morley JE. International Association of Gerontology and Geriatrics: A Global 
Agenda for Clinical Research and Quality of Care in Nursing Homes, J Am Med Dir 
Assoc 2011;12:184-9. 
[48] Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet 
2011;377:2226-35. 
CC
EP
T
D
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
23 
 
[49] Wei YJ, Simoni-Wastila L, Zuckerman IH, brandt N, Lucas JA. Algorithm for identifying 
nursing home days using Medicare claims and Minimum Data Set assessment data.  
Med Care 2016;54;e73–e77. 
[50] Williams RL. A note on robust variance estimation for cluster‐correlated data. Biometrics 
2000;56:645-6. 
[51] Won A, Lapane K, Gambassi G, Bernabei R, Mor V, Lipsitz LA. Correlates and 
management of nonmalignant pain in the nursing home. SAGE Study Group. Systematic 
Assessment of Geriatric drug use via Epidemiology. J Am Geriatr Soc 1999;47:936-42. 
[52] Won AB, Lapane KL, Vallow S, Schein J, Morris JN, Lipsitz LA. Persistent nonmalignant 
pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr 
Soc 2004;52:867-74 
[53] Won A, Lapane KL, Vallow S, Schein J, Morris JN, Lipsitz LA. Long-term effects of 
analgesics in a population of elderly nursing home residents with persistent nonmalignant 
pain. J Gerontol A Biol Sci Med Sci 2006;61:165-9. 
[54] Yong HH. Can attitudes of stoicism and cautiousness explain observed age‐related AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
24 
 
variation in levels of self‐rated pain, mood disturbance and functional interference in 
chronic pain patients? Eur J Pain 2006;10:399-407. 
[55] Zou G. A modified poisson regression approach to prospective studies with binary data. 
Am J Epidemiol 2004;159:702-6. 
[56] Zou GY, Donner A. Extension of the modified Poisson regression model to prospective 
studies with correlated binary data. Stat Methods Med Res 2013;22:661-70. 
 
AC
CE
PT
ED
Copyright  2017 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
25 
 
  
FIGURE LEGENDS 
Figure 1. Variation in the crude prevalence of persistent and intermittent pain by age, gender, race/ethnicity, cognitive 
impairment, and cancer. 
Figure 2. Pharmacologic pain management in long-stay nursing home residents by pain recorded at index assessment and 
in residents with persistent pain. 
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Table 1. Resident characteristics and correlates by pain reported in long-stay United States nursing home 
residents (N=1,387,405). 
 
 Pain Frequency 
 
Persistent pain  
vs. no pain 
 Intermittent 
pain  
vs. no pain 
Characteristicsa  
Persistent 
Pain 
(n=270,244)  
Intermittent 
Pain 
(n=265,982) 
 No   
Pain 
(n=851,179) 
 Adjustedb OR 
(95% CI)  
Adjustedb OR 
(95% CI) 
Age, years           
   18-64  19.4  12.5  12.7  1.07 (1.04–1.09)  0.89 (0.87–0.91) 
   65-74   16.6  13.3  12.6  Reference  Reference 
   75-84  27.1  27.7  27.0  0.88 (0.86–0.89)  1.03 (1.02–1.05) 
   ≥85   36.9  46.4  47.7  0.68 (0.66–0.69)  0.96 (0.94–0.98) 
Womenc  71.7  70.1  66.3  1.55 (1.53–1.57)  1.23 (1.21–1.24) 
Race/Ethnicity           
   Non-Hispanic White  84.2  82.4  76.9  Reference  Reference 
   Non-Hispanic Black  10.8  11.7  15.1  0.61 (0.60–0.63)  0.75 (0.73–0.76) 
   Hispanic  3.5  4.2  5.4  0.66 (0.63–0.69)  0.80 (0.78–0.83) 
   Other  1.5  1.8  2.6  0.54 (0.50–0.58)  0.67 (0.64–0.71) 
Physical functioningd           
   Moderate impairment  47.4  49.2  47.5  1.06 (1.04–1.08)  1.12 (1.10–1.13) 
   Severe impairment  26.5  29.4  31.7  1.10 (1.08–1.13)  1.05 (1.03–1.07) 
Cognitive functioningd           
   Moderate impairment  27.6  30.4  29.5  0.48 (0.47–0.49)  0.67 (0.66–0.68) 
   Severe impairment  22.9  47.4  50.3  0.26 (0.25–0.26)  0.48 (0.48–0.49) 
Reject caree  11.3  11.6  11.9  1.19 (1.17–1.22)  1.08 (1.06–1.09) 
Hospice usee  8.4  9.7  6.7  1.81 (1.77–1.85)  1.62 (1.59–1.65) 
Comorbiditiese           
   Dementia  38.4  53.0  64.7  0.55 (0.55–0.56)  0.71 (0.70–0.72) 
   Cancer  8.8  8.5  6.8  1.20 (1.18–1.22)  1.16 (1.14–1.18) 
   Arthritis   35.8  31.4  23.6  1.91 (1.88–1.94)  1.46 (1.44–1.48) 
   Osteoporosis  18.1  18.1  16.3  1.01 (1.00–1.03)  1.01 (1.00–1.02) 
   Fracture  5.4  4.9  2.4  2.25 (2.19–2.32)  1.98 (1.93–2.03) 
   Pressure ulcers  10.0  8.8  5.3  2.12 (2.08–2.17)  1.73 (1.69–1.76) 
   Surgical wounds  3.1  2.1  0.9  2.68 (2.58–2.79)  2.13 (2.05–2.22) 
Staff-assessed pain at  12.7  21.2  24.8  0.76 (0.74–0.78)  1.03 (1.03–1.05) 
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index assessment 
CI: confidence interval; OR: odds ratio 
aCharacteristics are percentages unless otherwise noted. Columns may not add up to 100% due to rounding. 
bAdjusted for all resident characteristics listed in table using a multinomial logistic model 
cReference group: Men 
dReference group: No/mild impairment 
eReference group: not having the behavior, service, or comorbidity (e.g., hospice use vs. no use). 
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Table 2. Correlates of untreated and potentially undertreated pain in long-stay nursing home 
residents with persistent pain (n=270,244). 
  Untreated Paina  Potentially Undertreated Paina 
Characteristic 
 % Adjusted
b
 PR 
(95% CI)  % 
Adjustedb PR 
(95% CI) 
Age, years       
   18-64  4.7 0.84 (0.79–0.89)  33.8 0.95 (0.93–0.97) 
   65-74   5.4 Reference  33.4 Reference 
   75-84  6.5 1.20 (1.14–1.26)  32.4 1.01 (0.98–1.03) 
   ≥85   7.6 1.42 (1.35–1.49)  30.1 0.97 (0.95–0.99) 
Womenc  6.1 0.76 (0.74–0.79)  30.6 0.91 (0.90–0.93) 
Race/Ethnicity       
   Non-Hispanic White  6.3 Reference  30.7 Reference 
   Non-Hispanic Black  7.1 1.19 (1.13–1.25)  39.2 1.23 (1.20–1.25) 
   Hispanic  5.7 0.87 (0.80–0.95)  38.9 1.18 (1.14–1.22) 
   Other  7.5 1.15 (1.03–1.29)  36.1 1.11 (1.05–1.17) 
Physical functioning       
   No / minor impairment  6.6 Reference  33.2 Reference 
   Moderate impairment  6.5 0.93 (0.90–0.96)  31.8 0.96 (0.95–0.98) 
   Severe impairment  6.0 0.85 (0.81–0.89)  31.3 0.93 (0.91–0.94) 
Cognitive functioning       
   No / minor impairment  5.1 Reference  30.6 Reference 
   Moderate impairment  6.9 1.24 (1.19–1.29)  33.1 1.11 (1.09–1.12) 
   Severe impairment  8.5 1.51 (1.44–1.57)  33.6 1.14 (1.11–1.16) 
Reject cared  6.8 1.03 (0.98–1.08)  33.3 1.02 (1.00–1.04) 
Hospice used  3.7 0.50 (0.47–0.54)  23.8 0.71 (0.69–0.73) 
Comorbiditiesd       
   Dementia  7.8 1.16 (1.12–1.20)  31.8 1.00 (0.99–1.02) 
   Cancer  5.0 0.81 (0.76–0.86)  29.3 0.93 (0.91–0.96) 
   Arthritis   5.2 0.69 (0.66–0.71)  25.2 0.73 (0.72–0.74) 
   Osteoporosis  5.7 0.92 (0.88–0.96)  26.2 0.87 (0.85–0.89) 
   Fracture  4.6 0.72 (0.67–0.78)  34.9 1.14 (1.10–1.17) 
   Pressure ulcers  4.4 0.70 (0.66–0.75)  29.5 0.90 (0.88–0.92) 
   Surgical wounds  3.2 0.58 (0.51–0.65)  36.6 1.11 (1.07–1.15) 
Staff-assessed pain at 
index assessmentd 
 7.6 1.05 (1.00–1.10)  34.4 1.09 (1.07–1.11) 
CI: confidence interval; PR: prevalence ratio 
aUntreated pain defined as receiving no analgesics at the index assessment. Potentially undertreated 
pain defined as receiving no scheduled analgesics at the index assessment. 
bAdjusted for all resident characteristics listed in table using modified Poisson models [56]. 
cReference group: Men 
eReference group: not having the behavior, service, or comorbidity (e.g., hospice use vs. no use). 
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